Lv1
38 积分 2022-07-26 加入
Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial
10小时前
待确认
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
10小时前
已完结
Long-Term Outcomes of Radiation Monotherapy Versus Combined Radiation Monotherapy + Hormone Therapy in Low-Risk Early-Stage Breast Cancer Patients 70 Years or Older After Breast-Conserving Surgery
4个月前
已完结
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
5个月前
已完结
Mendelian Randomization Study: The Impact of Gut Microbiota on Survival in HR+ Breast Cancer Patients Under Different Treatment Regimens through the Modulation of Immune Cell Phenotypes
5个月前
已完结
Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke
6个月前
已完结
Rbm39 ameliorates metabolic dysfunction-associated steatotic liver disease by regulating Apob and Fabp4
7个月前
已完结
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
7个月前
已完结
皖公网安备34019202002308
